RA
AH

Royce & Associates’s Accretive Health AH Stock Holding History

Royce & Associates’s Portfolio AH Stock Details AH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-179,000
Closed -$1.94M – 1497
2013
Q2 		$1.94M Buy
+179,000
New +$1.88M 0.01% 1057

Other funds holding AH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JRP
Jasper Ridge Partners Menlo Park, California $4.69B AUM 31.34% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
NRC
North Run Capital Boston, Massachusetts $43.5M AUM 38.24% 1-Year Est. Return
SCA
SAC Capital Advisors Stamford, Connecticut $19.3B AUM 31.93% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

Royce & Associates's AH Position: Q3 2013 in Review

Royce & Associates sold out of Accretive Health (AH) in Q3 2013, closing a stake of 179,000 shares — an estimated $1.94M sold.

Royce & Associates first reported a position in AH in Q2 2013 and held it in 1 quarter. The position peaked at $1.94M in Q2 2013. 99 funds tracked by Wall St. Rank hold AH as of Q3 2013.

  • Royce & Associates reported no remaining Accretive Health position as of Q3 2013 after selling out during the quarter.
  • Royce & Associates sold 179,000 Accretive Health shares in Q3 2013, an estimated $1.94M.
  • Royce & Associates first reported a position in Accretive Health in Q2 2013 and held it in 1 quarter.
  • Royce & Associates's Accretive Health position peaked at $1.94M in Q2 2013.
  • 99 funds tracked by Wall St. Rank held Accretive Health as of Q3 2013.

Based on Royce & Associates's 13F filing for Q3 2013, filed 12 Nov 2013.